| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Hayden Donald J Jr is a Director at INSMED Inc with holdings across 3 companies. Recent SEC Form 4 filings include 0 buys and 14 sells.
Estimated insider holdings value: $6.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 2, 2018 | FOLD Amicus Therapeutics, Inc. | Director | Sale+OE | 20,000 | $15.00 | $300,002.00 | -77.5% | |
| Nov 14, 2017 | INSM Insmed Inc | Director | Sale+OE | 15,000 | $32.50 | $487,500.00 | -21.1% | |
| Oct 11, 2017 | RGNX Regenxbio Inc. | Director | Sale+OE | 20,000 | $34.95 | $699,000.00 | -100% | |
| Sep 27, 2017 | RGNX Regenxbio Inc. | Director | Sale+OE | 20,000 | $32.45 | $649,000.00 | -100% | |
| Sep 18, 2017 | RGNX Regenxbio Inc. | Director | Sale+OE | 40,000 | $28.70 | $1,148,000.00 | -100% | |
| Sep 7, 2017 | INSM Insmed Inc | Director | Sale+OE | 45,000 | $29.67 | $1,335,000.00 | -21.1% | |
| Sep 5, 2017 | RGNX Regenxbio Inc. | Director | Sale+OE | 20,000 | $24.95 | $499,000.00 | -100% | |
| May 15, 2017 | RGNX Regenxbio Inc. | Director | Sell | 8,599 | $19.04 | $163,724.96 | -100% | |
| May 8, 2017 | RGNX Regenxbio Inc. | Director | Sell | 10,000 | $18.35 | $183,500.00 | -53.8% | |
| May 1, 2017 | RGNX Regenxbio Inc. | Director | Sale+OE | 30,000 | $22.26 | $667,735.58 | -32.4% |